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CORRELATED MORPHOMETRIC
AND BIOCHEMICAL STUDIES
ON THE LIVER CELL
II. Effects of Phenobarbital
on Rat Hepatocytes
INTRODUCTION
Phenobarbital belongs to the large and chemically
heterogeneous group of agents the metabolic con-
version of which induces in hepatocytes of verte-
brates (1, 2) a reversible adaptive response . The
metabolic situation of the "induced" hepatocyte is
mainly characterized by an increase in activity of
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ABSTRACT
The changes occurring in rat hepatocytes during a 5 day period of treatment with pheno-
barbital were determined by morphometric and biochemical methods, particular attention
being paid to the endoplasmic reticulum . The hepatocytic cytoplasm played an over-
whelming part in the liver hypertrophy, while the hepatocytic nuclei contributed to
only a moderate extent . The endoplasmic reticulum accounted for more than half of the
increase in cytoplasmic volume . The increase in the volume and number of hepatocytic
nuclei in the course of phenobarbital treatment was associated with changes in the ploidy
pattern. Until the 2nd day of treatment both the rough-surfaced endoplasmic reticulum
(RER) and the smooth-surfaced endoplasmic reticulum (SER) participated in the increase
in volume and surface of the whole endoplasmic reticulum (ER). Subsequently, the values
for RER fell again to control levels, whereas those for SER continued to increase, with the
result that by the 5th day of treatment the SER constituted the dominant cytoplasmic
element. The specific volume of mitochondria and microbodies (peroxisomes) remained
constant throughout the duration of the experiment, while that of the dense bodies increased.
The specific number of mitochondria and microbodies displayed a significant increase,
associated with a decrease in their mean volume . The phenobarbital-induced increase in the
phospholipid and cytochrome P-450 content of the microsomes, as well as in the activities of
microsomal reduced nicotinamide-adenine dinucleotide phosphate-cytochrome c reductase
and N-demethylase, was correlated with the morphometric data on the endoplasmic retic-
ulum.
several microsomal enzymes which may handle
either foreign (or xenobiotic, [3]) lipid-soluble
compounds (for reviews see 4-8) or endogenous
substrates (9) . Several observations indicate that
this stimulation is the result of de novo synthesis
(10-12). The oxidases (13) of these enzymes are,functionally, closely linked to or integrated into
an electron-transport chain which is also part of
the microsomal membranes (14-16) . Phenobar-
bital treatment of animals causes an increase in
the activity of some constituent enzymes of that
chain, such as NADPH-cytochrome c reductasel
(11, 17, 18) and cytochrome P-450 (3, 11, 19, 20) .
Furthermore, phenobarbital provokes an in-
crease in liver weight and, at the subcellular level,
a proliferation of smooth-surfaced membranes of
the endoplasmic reticulum (21, 22), though ap-
parently without drastically affecting the rough-
surfaced variety (21, 23). Since the structural
interdependences between rough-surfaced and
smooth-surfaced elements of the endoplasmic
reticulum are largely unknown, the dispropor-
tionate synthesis of one morphological variety
under the stimulus of phenobarbital might repre-
sent a valuable model for the study of biosynthetic
interrelationships between the two membrane
types.
This paper presents a correlative morphometric
and biochemical description of the changes in
hepatocytes caused by acute treatment of rats
with phenobarbital. The results of this study are
based on those reported in the preceding communi-
cation dealing with the untreated liver (24) .
MATERIAL AND METHODS
Animals
Male albino rats (Wistar-derived), weighing 176-
227 g and fed ad libitum with standardized laboratory
chow, were used.
Treatment
Sodium phenobarbital (100 mg/kg body weight),
dissolved in distilled water, was injected intraperitone-
ally on 5 consecutive days. The animals were fasted
for 24 hr prior to sacrifice in order to deplete glycogen.
Preparation of Microsomes
All experiments were started between 7 and 8 a. In.
The rats were lightly anesthetized with ether and
sacrificed by decapitation. Their livers were quickly
removed, weighed, and chilled in ice . The livers were
then homogenized in 5 volumes of 1.157 KCI with
the aid of a glass homogenizer equipped with a
1 The abbreviations used are : NADPH, reduced nicotin-
amide-adenine dinucleotide phosphate ; ER, endo-
plasmic reticulum ; RER, rough-surfaced endoplasmic
reticulum; SER, smooth-surfaced endoplasmic
reticulum.
Teflon pestle. Both homogenization and fractionated
centrifugation were performed at a temperature of
- 4°C. Following centrifugation at 800 g for 10 min
he resultant supernatant was centrifuged at 20, 000 g
for 20 min. Sedimentation of the microsomes was
achieved by submitting this supernatant to centrif-
ugation at 105,000 g for 60 min in a Spinco Model L
ultracentrifuge (Spinco Div., Beckman Instruments,
Inc., Palo Alto, Calif.) equipped with rotor No. 39.
Enzyme Assays
The results of biochemical assays represent
averages of six animals per dose. Enzyme activity
or content was expressed as indicated in the legend
to Fig. 6.
NADPH - CYTOCHROME C REDUCTASE : The
activity of this enzyme was determined essentially
according to Williams and Kamin (25) . NADPH
and cytochrome c were obtained from C.F.
Boehringer, Mannheim, Germany . The reduction
of cytochrome c was followed at 550 mµ in a Zeiss
PMQ II spectrophotometer. A millimolar ex-
tinction coefficient (mm-1 cm1) of 18.5 (26) was
used to calculate the concentration .
CYTOCHROME P-450 : The content of cyto-
chrome P-450 in the microsomes reduced by di-
thionite (30 mat) was determined by the method of
Klingenberg (27). The incubation system was
gassed with carbon monoxide for 1 min . The differ-
ence in optical density between 450 and 490 mµ
was taken as an estimate ofcytochrome P-450. The
relevant concentrations were calculated from the
optical density values, by using a millimolar ex-
tinction coefficient of 91 (28).
N-DEMETHYLASE : The assay system used was
that described by Orrenius et al. (29), except that
no nicotinamide was added (30). The formalde-
hyde formed was determined by the method of
Nash (31) .
Other Assays
Protein was estimated by the method of Lowry
et al. (32), with crystallized bovine plasma al-
bumin (Armour Co. Chicago, Ill.) as a standard .
For the determination of phospholipids the method
of Morrison (33) was employed.
Electron Microscopy
The tissue subjected to electron microscopic ex-
amination was removed from the same livers as
those used for the biochemical assays. The tissue
was prepared by the methods described in the
preceding paper (24).
STAUBLI, HESS, AND WEIBEL Morphometry and Biochemistry of Rat Liver . II
	
93Morphometry
As the general sampling and counting proce-
dures employed, as well as the methods of stereo-
logical analysis, have already been described in
detail in the preceding paper (24), we shall review
briefly the different sampling steps . Five animals
were used for each phenobarbital dose . From each
rat five tissue blocks were randomly selected . From
each block one large (-0.4 X 0.6 mm), thin sec-
tion was cut, from which altogether 12 randomly
chosen micrographs at two primary magnification
levels (six micrographs at 2500 X and six at 10,000
X) were made.
In contrast to our previous report (24), the
sampling level I was omitted. Hence, the extra-
lobular space of liver tissue was not estimated, and
the specific volumes of different compartments
refer strictly to lobular parenchyma . It was shown
in the foregoing paper that the extralobular space
accounts for roughly 4% of the total liver tissue.
Thus, in the present investigations, the extra-
hepatocytic space has been underestimated by 4%
in favor of the hepatocytes. The volume of the
hepatocytic nuclei was determined on -1 µ thick
Araldite sections stained with toluidine blue by
employing two independent methods, described in
detail in the preceding paper (24) : (a) morpho-
metric volumetry and (b) determination of the
diameters of the hepatocytic nuclear profiles using
a Zeiss Particle Size Analyzer. The profile diam-
eters were converted into nuclear diameters with
the aid of the Wicksell transformation (34). Some
350 nuclear profiles were measured per animal .
Computation and Statistical Treatment of
Results
The biochemical and morphometic values were
preferentially expressed per 100 g of body weight
"specific dimensions," but also in terms of the
average "mononuclear hepatocyte." Details of
computation are to be found in our preceding
paper (24). Individual biochemical and morpho-
metric data for each phenobarbital dose were
averaged, and the standard deviation of the mean
(standard error, fsE) was calculated . In order to
compare the means of different doses, Student's
two-sided t test was used . Two means were con-
sidered to differ significantly if the probability of
error P was smaller than 0 .05.
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RESULTS
Liver Growth
After 2 and 5 days of phenobarbital administra-
tion the relative liver weight of treated animals was
significantly higher than that of the controls (Table
I) . As the mean specific weight of the liver (de-
termined by pyknometry) did not change during
treatment, the observed increase in wet weight
reflects a proportionate increase in volume .
As shown in Fig. 1, in which the morphometric
data are reproduced in the form of a histogram, the
cytoplasmic compartment provided the largest
contribution to the liver hypertrophy. In compari-
son with the controls, the cytoplasm was already
TABLEI
Changes in Relative Liver Weight
* Level of significance.
$ Standard error.
significantly enlarged by the 2nd day of treatment,
and became further enlarged until the 5th day . The
total volume of the cytoplasmic compartment
increased by approximally I ml/100 g body
weight during the entire period of treatment. As
will be shown later, the endoplasmic reticulum
(ER) played the largest part in this increase. This
preponderance of the cytoplasm was also found at
the level of the individual hepatocyte : as can be
seen from Table II, the hepatocytic volume rose by
1032 µ3, or 217, (Fig. 14), during the 5 day period
of phenobarbital treatment ; during the same in-
terval of time the cytoplasmic volume increased by
993 µ3 (Table II), which is likewise equivalent to a
rise of 21 6 / 0 (Fig. 14).
In comparison with the controls, the specific
volume of the hepatocytic nuclei was significantly
elevated on the 5th day of phenobarbital treat-
ment (Fig. 2) ; its contribution to the increase in
liver volume was only moderate (approximately
0.05 ml/100 g body weight) after 5 days of pheno-
Relative liver weight
Duration of
treatment
Mean
body
weight
in g/100g body
weight
Increase
in
P*
9
Control 176.2 3 .6 ± 0.040$ -
16 Hr 227 .3 3 .7 f 0.050 2 .9 <0 .1
2 Days 186.2 4.1 f 0 .064 14 .2 <0 .001
5 Days 212 .7 4.6 t 0 .201 28 .5 <0 .001Days of phenobarbital treatment
barbital treatment (Fig. 1). The cell nucleus ac-
counted for some 40 Fi3 of the increase of 1032 °3
in hepatocytic volume measured at the end of the
period (Table II, Fig. 14) .
The specific number of parenchymal cell nuclei
was already significantly higher than in the con-
trols after the second phenobarbital injection and
remained at this elevated level throughout the
duration of the experiment (Fig. 2).
If the profile diameters of the cell nuclei meas-
ured in I ° thick Araldite sections were converted
into mean nuclear diameters with the aid of the
Wicksell transformation (34), the histograms re-
produced in Fig. 3 are obtained for the various
phenobarbital doses. In accordance with the ar-
bitrary procedure explained in the legend to Fig . 3,
these histograms were classified into three sizes,
the diploid cell nuclei (2n) being assigned to Class
I, the tetraploid (4n) to Class II, and the octaploid
(8n) to Class III. It can be seen from Fig. 3 that
the classification we have selected increases the
percentage share of the 8n nuclei at the expense of
the 2n nuclei, in comparison with the findings
reported by various authors (35, 36) in experi-
mentally dissociated cells from rat livers. This
discrepancy might be due to the arbitrary nature
FIGURE 1 The extent to which cyto-
plasmic (C), nuclear (N), and extra-
hepatocytic (X) space are involved in
liver growth induced by phenobarbi-
tal. The values for the cytoplasmic
space at 9 and 5 days are significantly
(P < 0.001) higher than those of the
control.
of our classification, to differences in the ages of
the rats (35), or to the fact that, when cell sus-
pensions are used, the yield of 2n cells is increased
(possibly because nonhepatocytic 2n cells are also
counted) and that the yield of the 8n cells is de-
creased for unknown reasons. In this connection, it
should be pointed out that on the basis of micro-
photometric DNA determinations in rat liver sec-
tions Alfert and Geschwind (37) arrived at a
ploidy pattern which is rather similar to ours
(Fig. 3). Whatever may be the reasons for these
discrepancies, the classification illustrated in Fig . 3
allows one to follow the relative shifts in nuclear
size as a function of the number of phenobarbital
doses. Fig. 4 shows, in the form of a histogram, the
changes in the incidence of nuclei belonging to the
three classes (I-III) at various times during pheno-
barbital treatment. After 16 hr the 2n nuclei
(Class I) had appreciably increased and the 8n
nuclei (Class III) had decreased, whereas the
percentage share of the 4n nuclei (Class II) had
undergone only a slight change . Along with this
shift in ploidy the specific number of nuclei rose
(Fig. 2). In the course of further phenobarbital
treatment, the percentage share of 8n nuclei in-
creased progressively, whereas that of the 2n and
STAUBLI, HESS, AND WEIBEL Morphometry and Biochemistry of Rat Liver . II
	
95TABLE II
Morphometric Parameters Expressed per Aaerage Mononuclear Hepatocyte
The values are not corrected for systematic errors (cf. reference 24) .
4n nuclei diminished (Figs. 3 and 4) ; at the same
time, the specific nuclear volume now also dis-
played a significant increase (Fig . 2) . Finally, it
should also be pointed out that the use of tissue
sections made it impossible to count binucleated
and multinucleated cells.
Protein and Phospholipid Content of
Microsomes
As illustrated in Fig . 5 the microsomal protein
did not increase significantly until the 5th day,
whereas the approximately 40% increase in
phospholipid was already highly significant by the
2nd day of treatment; after five doses of pheno-
barbital, the phospholipid content of the micro-
somes per 100 g body weight had doubled .
Enzyme Activity or Content of Microsomes
Fig. 6 illustrates the activation of some constit-
uent microsomal enzymes as a function of the
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duration of phenobarbital treatment. All the
enzyme activities investigated underwent a highly
significant increase by the 2nd day of treatment at
the latest, irrespective of the terms of reference
selected (per milligrams of protein, per total liver,
or per 100 g body weight). In agreement with other
authors (11, 29), we found that the activity of
NADPH-cytochrome c reductase and of N-de-
methylase, as well as the P-450 content, increased
in roughly linear fashion along with the number of
phenobarbital doses. It should be mentioned,
however, that, in contrast to the findings of
Ernster and Orrenius (11, 29) and in agreement
with other reports (8, 19), we found an asynchron-
ous increase in activity 2 of the different micro-
2 These differences in the rate at which the activity of
individual microsomal enzymes increased could result,
however, from the fact that we have not established
optimal assay conditions for each enzyme tested .
For example, we observed, in agreement with Gram
Duration of phenobarbital treatment
Component Control 16 hr 2 days 5 days
Number of nuclei per 100 g body weight 568 X 106 620 X 106 645 X 106 640 X 106
Hepatocyte
Volume (µ3) 4,938 4,806 5,225 5,970
Volume of nuclei (µ3) 298 276 294 337
Volume of cytoplasm (p 3) 4,640 4,530 4,931 5,633
Endoplasmic reticulum
ER Volume (µ3) 756 1,160 1,186 1,734
Surface (p2) 63,000 81,600 88,840 95,160
Rough ER Volume (p3) 467 666 591 516
Surface (p2) 37,900 41,000 41,860 37,500
Smooth ER Volume (µ3) 289 494 595 818
Surface (µ2) 25,100 40,600 46,980 57,660
Number of bound ribosomes 12 .7 X 106 17 .7 X 106 17 .0 X 106 14 .7 X 106
Mitochondria
Volume (,0) 1,070 1,016 1,163 1,094
Number 1,665 1,693 1,628 2,203
Microbodies
Volume (µ3) 67 53 57 59
Number 370 439 713 708
Dense bodies
Volume (µ3) 41 31 40 593
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somal enzymes (Fig . 6) . The emergence of the in-
dividual microsomal enzyme activities during
postnatal differentiation of rat hepatocytes also
follows differential kinetics (38).
Cytoplasmic Components
VOLUME OF THE ER : The specific volume
of the entire ER increased significantly throughout
and Fouts (39), a marked stimulation of aminopyrine
demethylase by using HEPES buffer instead of Tris
buffer.
Volume of nuclei
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FIGURE 2 Changes in volume and number of hepatocytic nuclei : (The figures on the right of the ordinate
(0.1-0.3) refer to the nuclear volume, and those on the left (1-4) to the specific volume of the liver and
the cytoplasm) . The nuclear volume was determined by morphometric volumetry (solid line) or by
measuring the nuclear profiles and then applying the Wicksell transformation (hatched line) on 1 µu thick
toluidine blue-stained Araldite sections . The value at 5 days was significantly (P < 0 .01) higher than
the control value. Why the volumes arrived at by using the Wicksell transformation should be 10-15%
below those ascertained by morphometry is not known ; the discrepancy might perhaps be connected with
the fact that the geometrical simplifications introduced in the course of the Wicksell transformation
(34) give rise to a systematic error . As regards the specific number of hepatocytic nuclei, the morphometric
values (solid line) tally well with those obtained from the Wicksell transformation (hatched line) . The
value on the 2nd day of phenobarbital treatment differed to a weakly significant extent (P < 0 .05) from
the control value. For a detailed description of the procedures and computations used, see the preceding
paper (24). For comparison, the specific volume of whole liver and of hepatocytic cytoplasm is shown .
Standard errors are indicated .
the duration of treatment, whereas the correspond-
ing values for the RER were significantly higher at
5 days (Fig. 7) . The values for the volume of ER,
RER, and SER per mononuclear hepatocyte are
summarized in Table II, whereas Fig . 13 shows the
percentage change in these values during the
course of phenobarbital treatment.
SURFACE O F THE ER : The results of mor-
phometric surface determinations are summarized
in Fig. 8. The specific surface of the entire ER
showed the most pronounced increase (+38%)
STÄUBLI, HESS, AND WEIBEL Morphometry and Biochemistry of Rat Liver. II
	
9720
.Y
u
C
W o
o
10
Y
IL
R
o
o
°10 u
o .
20 .6
u
C
N o
o
,` 10
o .
I
16 Hours
98
	
THE JOURNAL OF CELL BIOLOGY • VOLUME 42, 1969
during the first 16 hr. Both the SER (+58%) and
the RER (+23%) were involved in this increase .
After 16 hr of treatment the surface ratio of SER to
RER was raised from 0.75 in the controls to ap-
proximately 1 .
During the period between 16 hr and 2 days the
specific surface of the RER remained constant,
whereas that of the SER increased further (+24%),
though at a slower rate (Fig. 8) . Between the 2nd
and the fifth day of treatment the surface of the
SER increased by approximately 8 m2 per 100 g
body weight, while that of the RER decreased by
about 5.1 m2 to the control levels. During this
period the surface of the entire ER showed no
more than a slight increase.
Although the specific volume of the SER on the
fifth day of treatment was 4 times greater than the
control value and the specific surface was only 2 .5
times greater, the surface-to-volume ratio of the
SER did not differ to a significant extent from the
corresponding ratio of controls at any point during
the experiment.
Table II reveals that in the course of the 5-day
period of phenobarbital treatment the surface of
the SER of the hepatocyte increased from 25,100
µ2 to 57,660 µ2, i.e. by 130% (Fig. 13).
RIBOSOMAL LOADING OF THE RER : As
Fig. 9 shows, the packing density of the ribosomes
on the surface of the RER membranes increased
much more markedly than the latter's specific
surface. In the first 16 hr of phenobarbital treat-
ment the number of membrane-bound ribo-
somes per 100 g body weight showed a signifi-
cant rise from 73 X 1014 to 115 X 1014, and
remained at this level until the 2nd day of treat-
ment. Between the 2nd and the 5th day of treat-
ment the number of ribosomes decreased to the
control values, as did the specific surface of the
RER.
FIGURE 3 Distribution of nuclear diameters. The
classification is based on the following assumptions :
(a) The mean diameter D of the nuclear population in
the controls was taken as being equal to the mean
diameter of the tetraploid (4n) nuclei occurring most
commonly in the adult liver (35) ; (b) The volume of
diploid (2n) nuclei was half and the volume of octaploid
(8n nuclei) twice that of the 4n nuclei . Hence, Class I
contains the 2n nuclei with a diameter d < 6.6 Ft,
Class II the 4n nuclei with a diameter of 6.6 µ < d
8.9 µ, and Class III the 8n nuclei with a diameter
d > 8.9 ,u. Each histogram is based on about 1,700
measurements.70-
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A mononuclear hepatocyte contains approxi-
mately 13 million membrane-bound ribosomes
(Table II) ; the highest value was attained 16 hr
after the commencement of phenobarbital treat-
ment and amounted to some 18 million, which is
equivalent to an increase of 40% (Fig . 13).
VOLUME OF CYTOPLASMIC PARTICLES : The
specific volume of mitochondria and microbo-
dies did not change throughout the period of
phenobarbital treatment, whereas that of the
1
5
FIGURE 4 Histogram showing the
frequency distribution of nuclear di-
ameters in the three classes (I-III) as
defined in the legend to Fig. 3.
FIGURE 5 Changes in protein and
phospholipid content of microsomes.
By the 2nd day of treatment, the in-
crease in phospholipid is already
highly significant (P < 0.001),
whereas the increase in protein is only
weakly significant (P < 0.05) after
5 days. *The control values, in mg per
100 g body weight, are 89 .9 f 8.92
(f sE) for the protein and 43.4 f
2.86 for the phospholipid . The stand-
ard error is f7% for the phospho-
lipid and phospholipid/protein ratio,
and ±10% for the protein.
dense bodies increased significantly in comparison
with the control values on the 5th day of treatment
(Fig. 10) . The relative constancy in the volume
of the mitochondrial and peroxisomal compart-
ment in the hepatocytes is also apparent from
Table II and Fig. 14.
NUMBER AND MEAN VOLUME OF CYTO-
PLASMIC PARTICLE : On the 2nd and 5th day
of treatment the number of mitochondria per
100 g body weight showed a significant increase
STÄUBLI, HESS, AND WEIBEL Morphometry and Biochemistry of Rat Liver. II
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in comparison with the control values, whereas
their mean volume decreased between the 2nd
and the 5th day (Fig. 11). The same trend can
be observed when the values are related to the
individual parenchymal cell (Table II, Fig . 14) .
We also determined the following parameters of
mitochondrial structure : surface of the internal
membranes/surface of the external membrane,
(the inner layer of the external membrane being
included among the internal membranes), sur-
face/volume ratio of the internal membranes,
and surface/volume ratio of the external mem-
brane. In none of these parameters did pheno-
barbital treatment cause any significant changes .
The corresponding values for the controls have
already been given in the preceding paper (24).
Fig. 12 shows that the specific number of micro-
bodies doubled in the first 2 days of treatment,
this increase being highly significant ; the number
then remained at this level from the 2nd to the
5th day of treatment. As the specific volume of
the microbodies did not change throughout the
duration of the experiment (Fig. 10), the in-
crease in their number is connected with a
significant reduction in their mean volume oc-
curring by the 2nd day of treatment (Fig . 12) .
Table II and Fig. 14 show the behavior of these
4
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5
two microbody parameters in terms of the average
hepatocyte.
DISCUSSION
The morphometrically determined, quantitative
data on surfaces and volumes of subcellular
structures in the hepatocytes of untreated rats
have already been extensively discussed in the
preceding paper (24).
We must also consider briefly the question of
the extent to which the lobular structure of the
liver might have affected our results . According
to the observations of Burger and Herdson (40),
the centrolobular cells of rat liver react, to begin
with, in a characteristic manner to phenobarbital
stimulation; in the further course of phenobarbital
treatment (for up to 10 days), the subcellular
changes spread to the entire lobule. On the other
hand, Remmer and Merker (21) report that the
peripheral hepatocytes react most sharply to
phenobarbital . Orrenius and Ericsson (41) point
out that the response of individual hepatocytes
varies following phenobarbital administration.
Our morphometric studies were based on random
sampling of the liver tissue, no account being
taken of the localization of the hepatocytes within
the lobule. In the light of the above-mentioned,
FIGURE 6 Changes in enzyme activi-
ties or content of microsomes. With
the exception of NADPH-cytochrome
c reductase, all the values differed
highly significantly (P < 0 .001) from
the controls 16 hr after the first dose
of phenobarbital. After 2 days the
NADPH-cytochrome c reductase ac-
tivity was likewise significantly higher
(P < 0.001) . The control values, per
100 g body weight, are 0 .21 f 0.023
(f SE) µmoles/min for NADPH-
cytochrome c reductase (Reduct .),
19.69 f 3.37 µmoles for cytochrome
P-450 (P-450), and 3.70 f 1.05 µg for-
maldehyde/30 min for N-demethylase
(Demeth.). Hatched lines : values ex-
pressed per 100 g body weight ; solid
lines: values expressed per milligram
microsonial protein.3
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to some extent contradictory observations, it
might be supposed that the results recorded by us
tend to be minimum values; this limitation would
apply particularly to the early stages of pheno-
barbital treatment.
Liver Growth
After five phenobarbital doses the relative
weight of the liver, and thus its volume, had
increased by about 30% (Table I) ; in absolute
values, the increase in volume amounted to
approximately 1 ml (per 100 g body weight) .
As Fig. 1 shows, the cytoplasm of the hepatocytes
contributed the overwhelming part, whereas the
extrahepatocytic space displayed, if anything, a
tendency to decrease, although this decrease was
not statistically significant. Although the specific
volume of the hepatocytic nuclei underwent a
significant increase (Fig. 2), its contribution to
FIGURE 7 Changes in the specific
volume of total (ER), rough-surfaced
(RER), and smooth-surfaced (SER)
endoplasmic reticulum. The levels of
significance, as compared with con-
trols, are for ER at 16 hr P < 0 .01,
at 2 days P < 0.001, and at 5 days
P < 0.01; for RER at 16 hr and 2
days P < 0.01 ; for SER at 2 days
P < 0.001 and at 5 days P < 0.01 .
Standard errors are indicated .
the liver hypertrophy was to be regarded as slight
(Fig. I).
In agreement with Schulte-Hermann et al .
(42), we found an increase in hepatocytic nuclei
in the livers of phenobarbital-treated animals
(Fig. 2). As the incidence of binucleated and
multinucleated cells was not determined, it
cannot be decided whether this increase resulted
from an increase in multinucleated hepatocytes
or from cellular proliferation.
At all events, in view of the results shown in
Figs. I and 2, it must be assumed that the hepa-
tomegaly induced by phenobarbital was due
largely-but not exclusively-to an increase in
hepatocytic cytoplasm (cf. also Table II and
Fig. 14). This finding is to some extent in con-
trast to the data reported by Kunz et al. (43)
and Barka and Popper (44), who consider pheno-
barbital-induced liver growth to be exclusively
STXUBLI, HESS, AND WEIBEL Morphometry and Biochemistry of Rat Liver. 11
	
101the result of a hepatocytic enlargement in which
the nuclear compartment is not involved at all .
However, it could be inferred from the sig-
nificant increase in the number and volume of
hepatocytic nuclei (Fig. 2) and the changes in
nuclear size distribution (Figs. 3 and 4) that
mitoses occur during phenobarbital-stimulated
liver growth. In fact, several authors (10, 40, 45)
have reported an increase in mitoses in the liver
of phenobarbital-treated rats . More specifically,
the pattern of nuclear size distribution represented
in Fig. 4 is reminiscent of the findings of Nadal
and Zajdela (35), according to whom the ap-
pearance of nuclei of higher ploidy in developing
and regenerating rat livers is preceded by an
increase in the umber of binucleated parenchymal
cells. Although we did not determine the in-
cidence of binucleated cells, it might be assumed,
in line with the observations of Nadal and Zajdela
(35), that the increase in 2n nuclei (possibly
contained in binucleated diploid cells) occurring
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16 hr after the commencement of phenobarbital
treatment is causally connected with the increased
proportion of 8n nuclei seen after 5 days of treat-
ment (Fig. 4). This postulated selective increase
in the incidence of binucleated diploid cells
could also explain why the number of nuclei was
already elevated 16 hr after the commencement
of phenobarbital treatment, while the nuclear
volume remained initially unchanged (Fig. 2) .
Whatever might be the functional meaning of
polyploidization (cf. references 46, 47), it should
be mentioned that ploidy shifts occur not only in
hepatic differentiation and regeneration (35, 36,
48, 49), but also, for example, following carbon
tetrachloride poisoning (50) and in the course of
experimental inflammatory processes (51) .
Attempts to Correlate Morphometry and
Biochemistry
As regards drug metabolism, the surface of the
ER-particularly the surface of the smooth-
FIGURE 8 Changes in the specific
surface of total (ER), rough-surfaced
(RER) and smooth-surfaced (SER)
endoplasmic reticulum . The levels of
significance, as compared with con-
trols, are for ER at 16 hr P < 0.01;
at 2 and 5 days P < 0.001; for RER
at 2 days P < 0.01 ; for SER at
16 hr P < 0.01 and at 2 and 5 days
P < 0.001. Standard errors are
indicated.x1014
3
o0 a
o'
o
o
N
CL
E
ç
N
o
0
w`
0
005
e
N v
o 0 .04
O
U
É
ô
0
É 002
7
u 001
U
N a N
0.03
0
	
1
	
2
	
3
	
4
Days of phenobarbital treatment
Mitochondria
Microbodies
1
	
1
0
	
1
	
2
	
3
	
4
Days of phenobarbital treatment
surfaced variety-is more relevant from the
point of view of function than the volume of the
ER. The reasons for this are as follows :
1 . Over the entire period of treatment the
specific surface of the ER increased by approxi-
mately 25 m2 (per 100 g body weight) ; of this
5
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FIGURE 9 Changes in ribosomal load-
ing of rough-surfaced membranes . The
values at 16 hr and 2 days differ sig-
nificantly (P < 0 .01) from the con-
trols. For comparison, the specific
surface of RER (cf. Fig. 8) is shown.
Standard errors are indicated.
FIGURE 10 Changes in specific vol-
ume of mitochondria, microbodies, and
dense bodies. The value of dense
bodies after 5 days of treatment is
significantly (P < 0.01) higher than
the control. Standard errors are in-
dicated.
value, some 24 m2 was accounted for by the SER
alone (Fig. 8) . In agreement with the findings
reported by other authors (10, 22, 29, 52-58),
this proliferation of the ER was reflected in an
increase in microsomal proteins (Fig . 5). In
common with Ernster and Orrenius (11), we
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found that the microsomal phospholipid content cumulation of SER elements in hypertrophied
increased at a faster rate than the protein (Fig . 5). livers. The assumption is supported by the ob-
This disproportionate rise in the phospholipid servations of other authors (22, 29) who have
content was no doubt due to the preferential ac- reported that the phospholipid content of en-
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FIGURE 11 Changes in specific num-
ber and mean volume of mitochon-
dria. After 2 and 5 phenobarbital
doses the values of specific number
differ significantly from the controls
(P < 0.05 and P < 0.01, respec-
tively) . Standard errors are indicated.
FIGURE 12 Changes in specific num-
ber and mean volume of microbodies .
For specific number, the level of sig-
nificance is P < 0.001 at 2 and 5 days.
The mean volume, as compared with
the controls, is significantly decreased
(P < 0.05) by the 2nd and 5th day
of treatment. Standard errors are
indicated.riched SER fractions of phenobarbital-induced
livers increases more markedly than that of the
corresponding RER fractions .
2. The electron-transfer chain, which par-
ticipates in the oxidation of foreign substances
(and probably also of endogenous substrates
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[9]), is a constituent component of the ER mem-
branes and probably also develops a greater
activity in the SER than in the RER (39, 59, 60).
Furthermore, the extent to which substrates for
hydroxylation are bound is proportional to the
concentration of the terminal oxidase in this
i
5
T
5
Nmb
Nmi
VC.Vh
Nn
Vn
Vmi
FIGURE 13 Percentage changes, in
terms of an average hepatocyte, in
volume (V) and surface (S) of the
various components of the endoplas-
mit reticulum. N„, : Number of
membrane-bound ribosomes.
FIGURE 14 Percentage changes, in
terms of an average hepatocyte, in
volume (V) and/or number (N) of
Vmb
	
hepatocytes (h), cytoplasm (c), cell
nuclei (n), mitochondria (mi), and
microbodies (mb).
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FIGURE 15 Correction of the specific
A SER
•
corr.
	
surface of total (ER), rough-surfaced
(RER), and smooth-surfaced (SER)
endoplasmic reticulum for membrane
ER uncorr.
	
catabolism. As explained in the text,
_
	
the increments in the various ER
_
	
-'
	
SERuncorrA membranes in relation to the controls
RER corr
	
(0 uncorrected) can be linearized on
A the assumption that the increments
recorded in response to phenobarbital
(0 corrected) are the result of
accelerated synthesis and reduced
break down operating simultaneously .
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FIGURE 16 Linear relationship between the increments in specific surface of smooth-surfaced endoplasmic
reticulum (SER) and in activity or content of microsomal enzymes. As described in the text, not only the
surface increments of the SER can be corrected for inhibited breakdown in response to the various doses of
phenobarbital (arrows) (A specific surface of SER (corrected)), but also the increase in the activity of
the constituent ER enzymes in relation to the control value (,L activity or content [corrected]) .
chain, cytochrome P-450 (61, 62), and hence attempts to correlate morphometric and bio-
to the membrane surface of the ER . In view of chemical findings.
these considerations, the surface of the ER or
	
Ernster et al. (11, 29), and Orrenius and
SER was selected as reference parameter in our Ericsson (41) have obtained evidence that theincrease in cellular membranes induced by
phenobarbital treatment can be attributed to
de novo synthesis. On the other hand, Shuster and
Jick (57), in the light of kinetic studies on liver
microsomes of phenobarbital-treated mice, came
to the conclusion that the accumulation of mem-
branes must be regarded as the result of a simul-
taneously operating acceleration of synthesis and
inhibition of catabolism of ER membranes . It
can be deduced from Fig . 8 that the specific
surface of the ER and of its two structural com-
ponents does not increase linearly in function of
the time. We have converted the data on which
Fig. 8 is based in order to shed some light on the
characteristics of membrane development ; for
this purpose, the following assumptions were
made
1 . For each phenobarbital dose we used the
increments (denoted by the symbol A in Figs .
15 and 16) in the specific surface of the different
ER membranes with respect to the controls,
instead of the absolute values.
2. In line with the findings of Shuster and Jick
(57) we assume a phenobarbital-induced pro-
longation in half-life from 3 .5 to 7 days for the
preexisting and newly formed ER membranes .
The catabolic decay of membranes was assumed
to be of constant rate . The results of this cor-
rection are illustrated in Fig . 15. It can be seen
that, in agreement with Fig. 8, the absolute
increase (A uncorrected) in the specific surface
of the ER membranes is not linear in function
w w
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M
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of time ; if, on the other hand, the surface in-
crement is regarded as the result of de noao syn-
thesis and catabolism, a reasonable linearization
of the surface increment (A corrected) is ob-
tained. In other words, during the first 5 days of
phenobarbital treatment the ER membranes
appear to be synthesized at an approximately
constant rate.
We then corrected the increments of the other
ER parameters-e.g. microsomal content of
phospholipids (Fig. 5) and of cytochrome P-450
(Fig. 6), and the activities of the other constituent
membrane enzymes (Fig. 6)-in the same way
as for the ER membranes in order to allow for
degradation (63) . As the enzyme activities were
determined in the total microsomal fraction
(SER and RER), the activity or content in-
crements had to be distributed among the cor-
rected SER and RER surface increments . Finally,
the surface increments (corrected) could be
plotted against the activity increments (corrected) ;
Fig. 16 shows that, on the premises we selected, a
colinearity between proliferation of the ER mem-
branes (as measured by morphometry) and
synthesis of their constituents (as assayed by
biochemical methods) becomes apparent . This
kinetic agreement suggests that with these two
methods one and the same process-e.g. mem-
brane synthesis-is being observed at two differ-
ent levels of organization (individual constituent
molecules versus assembly of those molecules to
form a membrane) .
5
FIGURE 17 Change in loading of
membranes of the endoplasmic re-
ticulum (ER) with phospholipids. The
value at 16 hr is significantly (P <
0.05) smaller than the control value.
Standard errors are indicated .
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increments in the individual ER parameters as to
their whole amount, a comparison of Figs . 5, 6,
and 8 shows that, in the first 16 hr after the
injection of phenobarbital, for example, the spe-
cific surface of the entire endoplasmic reticulum
(ER in Fig. 8) increases more rapidly than that of
the other membrane components (Figs . 5 and 6) .
If the ratio mg phospholipid per unit of ER sur-
face is taken as a measure of surface loading for
the various phenobarbital doses, the degree of
loading will be found to be significantly reduced
16 hr after injection (Fig . 17). If the surface load-
ing of the ER membranes with enzymes is cal-
culated in a similar way, a more or less pro-
nounced deficit-except in the case of N-de-
methylase-will likewise be found to occur 16
hr after the administration of phenobarbital.
Assuming a loss of about 507 0 of microsomal
phospholipid during differential centrifugation
(64, 65) and a mean molecular weight of 800 for
an average phospholipid molecule, we can cal-
culate that the latter would occupy an area of
approximately 100 A2. This value is of the same
order of magnitude as that reported for natural
or synthetic phospholipid membranes (66-68) .
In membranes with a relative phospholipid def-
icit (Fig. 17), the area occupied by a phospho-
lipid molecule would have to increase to about
150 A2; a similar situation is encountered in soaps
in which, as their concentration decreases, the
area occupied by their polar groups increases
(69) .
Any discussion about the extent to which the
occurrence of ER membranes relatively depleted
of structural elements and enzymes (Fig. 17)
has a bearing on membrane structure and de-
velopment (phase transitions, cf. references 70,
71) and drug metabolism (binding of the sub-
strates and removal of the more hydrophilic
reaction products; interactions between con-
stituent enzymes and lipids [72-74]) will continue
to be highly speculative until relevant biochemical
data are available. In addition, it is conceivable
that the deficits we observed are due to the fact
that the distribution of the ER membranes among
the individual subcellular fractions differs quan-
titatively at various points in time during pheno-
barbital induction ; morphometric analysis on the
other hand is invariably based on the entire ER
present in situ.
As already mentioned, the number of mem-
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bran-bound ribosomes increased most markedly
during the first 16 hr of phenobarbital treatment
(Fig. 9). It is striking to note that this time is also
the time at which the ER membranes underwent
their sharpest increase (Figs . 7 and 8). As the
specific surface of the RER (Fig. 8), increased to
a lesser extent than the number of ribosomes
(Fig. 9), the RER surface must be more densely
loaded with ribosomes. Kato et al. (56) found
in the livers of phenobarbital-treated rats a
greater amount of membrane-bound ribosomes
which was similar in extent to our values . Find-
ings from the same (54, 56, 75) and another
laboratory (76) revealed that the amino acid
incorporation by liver microsomes is stimulated
by phenobarbital; this observation, too, could
be accounted for by a more dense loading of the
enlarged specific surface of the RER (Fig. 8)
with ribosomes.
Membrane Synthesis and Conversion
The model of membrane synthesis which has
been most extensively studied to date is the post-
natal proliferation of the ER in rat hepatocytes .
As regards our observations, the relevant results
of these investigations conducted by Omura
et al. (77) and Dallner et al . (38, 65, 78) are
briefly as follows :
1 . The increase in the ER membranes takes
place in two phases, inasmuch as the enlargement
of the RER portion precedes chronologically the
increase in SER ; this sequential appearance of
RER and SER and the large measure of agree-
ment between their respective chemical composi-
tions suggests that the mechanism of smooth-
membrane generation is based on a possibly
reversible detachment of ribosomes from the RER.
2. The ribosomes on the rough-surfaced mem-
branes are densest at the time when the RER is
growing at its fastest rate.
3. The morphological and biochemical evi-
dence as a whole is most readily compatible with
a model of membrane synthesis based on the
expansion of a preexisting membranous frame-
work, the individual constituent components of
which enter and leave the macromolecular as-
sembly at varying rates (asynchronously) .
Before we compare the events occurring in
phenobarbital induction with those encountered
in hepatocytic differentiation, reference must be
made to two further points. As already explained
in the previous paper (24), in our morphometricdeterminations of the volume and surface of the
ER we adopted the convention that measuring
points falling on ribosome-free stretches of RER 3
should be allocated to the SER . In other words,
our measurements did not differentiate between
ribosome-free zones belonging, as regards their
structural appearance and subcellular localiza-
tion, to the RER and "typical" SER which
appears in the form of a tightly meshed network
of smooth-surfaced tubules and vesicles. Owing
to this convention, it is, for example, impossible
to ascertain how much of the phenobarbital-
induced increase in SER surface is accounted
for by "intercalated" SER and how much by
typical SER. As, however, ribosomal loading of
the rough-surfaced membranes is significantly
increased 16 hr and 2 days after the administration
of phenobarbital (Fig. 9), the intercalated SER
may not make a substantial contribution to the
increment in the specific surface of the SER .
Phenobarbital-induced proliferation of ER
in the hepatocytes of male mice (57, 63) and rats
(79) is the outcome of a simultaneously operating
stimulation of membrane synthesis and inhibi-
tion of membrane catabolism. This factor ob-
scures the conditions obtaining during drug
induction; it is, for example, not known whether
degradation is slowed down to the same extent
in both types of ER membrane. In addition, the
studies conducted by Holtzman and Gillette (79)
suggest that the half-life of microsomal phos-
pholipids, which represents the net product of
synthesis and catabolism, may not remain con-
stant during phenobarbital induction.
After these remarks, we can now compare the
two models of membrane proliferation-hepato-
cytic differentiation and phenobarbital induc-
tion. In contrast to the conditions obtaining in
the differentiation model (38, 65, 77, 78), mem-
brane growth following repeated administration
of phenobarbital does not take place in two phases ;
on the contrary, RER and SER increase simul-
taneously in volume (Fig . 7) and surface (Fig .
8). the volume and surface of the entire ER
rising towards a new steady state (Figs. 7 and 8).
In the case of prenatal and postnatal differenti-
ation of liver parenchymal cells, the sequential
3 To make these remarks easier to understand, we
should like, for the purposes of the present study, to
use the term "intercalated SER" to denote that
portion of the SER which is inserted mosaic-like
between rough-surfaced cisternal stretches.
increase in RER and SER clearly suggests that
the RER plays the role of a precursor, with the
transformation of RER into SER being brought
about by the detachment of ribosomes from rough-
surfaced cisternae within a relatively short time
(a maximum of 3 days) . In the case of pheno-
barbital induction, the morphogenetic correla-
tions between RER and SER are less obvious,
probably because of the influence exerted, as
already mentioned, by membrane catabolism ;
the SER must develop as a result of a continuous
process taking place at the same time as RER
synthesis. This mechanism might consist of a
budding-off (41) of smooth-surfaced elements on
the cisternal ends of the RER, which would
account for the continuities frequently observed
(23, 41, 80, 81) between the two types of mem-
brane (Fig. 18) . If one accepts the hypothesis
that the whole of the SER is derived from the
RER as a result of ribosomal detachment, it can
be calculated that this transformation may as-
sume considerable proportions . On the assump-
tion that the phenobarbital-induced inhibition
of catabolism (57) affects RER and SER to the
same extent, some 17 m2 of RER per 100 g body
weight must be formed in the first 16 hr after the
administration of phenobarbital ; of this value,
9.4 m2 (or roughly 0.6 m2/100 g body weight per
hr) must be transformed into SER, 5 .1 m2/100 g
body weight remaining in the RER as a net
gain (Fig. 8) . The remaining 2.5 m2 would then
be degraded .
During the postnatal differentiation processes
in the hepatocyte the loading of cisternal surface
with ribosomes is at its maximum at the time
when RER proliferation is proceeding at its
fastest rate (65) . Similar conditions are encount-
ered in the phenobarbital-induced growth of the
ER membranes (Fig. 9) ; this similarity suggests
that the RER is expanded mainly by the mosaic-
like incorporation of intercalated SER, which
would have to be occupied by ribosomes im-
mediately after insertion into the performed
rough-surfaced cisternae. This process might be
responsible for the enlargement in the RER
surface and simultaneous increase in ribosomal
loading observed in both models ; the number of
membrane-bound ribosomes would thus have to
increase considerably (Fig. 9), and the increased
demand for constitutive membrane proteins
could then be met . In this case, the RER - s SER
transformation would have to be regarded as a
STAUBLI, HESS, AND WEIBEL Morphometry and Biochemistry of Rat Liver. II
	
109FIGURE 18 Part of the cytoplasm of a hepatocyte after 5 days of phenobarbital treatment, showing a
zone of close spatial relationship (arrows) between RER and SER . X 60,000.
vectorial flowing-off of SER elements-accom-
panied at the same time by detachment of mem-
brane-bound ribosomes-from the cisternal ends
(Fig. 18). This hypothetical course of events
would be compatible with the framework model
designed by the group of Palade (38, 77) and
discussed at the beginning of this section .
Cytoplasmic Particles
Phenobarbital stimulates certain oxidizing
functions of the liver mitochondria (82). The
specific volume of these mitochondria did not
change throughout the duration of treatment, but
their number increased between the 2nd and
5th day of treatment while the mean volume
decreased. Those structural parameters of the
mitochondria which might perhaps provide the
most direct measure of their oxidizing function-
such as, for example, the ratio between the sur-
face of the internal membranes and the volume-
did not undergo any substantial change. We
demonstrated in a previous study that the ad-
110
	
THE JOURNAL OF CELL BIOLOGY • VOLUME 42, 1969
ministration of chlorophenoxyisobutyrate is fol-
lowed not only by SER proliferation but also by
an increase in the peroxisomes' share of the volume
(83, 84). Phenobarbital, on the other hand, did
not affect the specific volume of the microbodies
(Fig. 10) ; in line with morphological observations
(40), all that could be seen was an increase in
number accompanied by a decrease in mean
volume. At present we are unable to explain
these changes.
Of the cytoplasmic particulate structures, only
the dense bodies showed, towards the end of
treatment, an appreciable increase in specific
volume (Fig. 10), which may possibly be con-
nected with the intracellular break down of
organelles (40, 85). Like other authors (21, 23),
however, we were unable to find any major
structural changes in our preparations. Schmid
et al. (86) recently reported that cytochrome
P-450 found in the ER membranes constitutes an
important precursor of bile pigments and that
phenobarbital markedly stimulates the trans-formation of microsomal hemoprotein into
bilirubin. In view of the occurrence of enzymes
possessing a high phospholipase activity in rat
liver lysosomes (87), these organelles might con-
ceivably be involved in this process in a way sug-
gested by the observation of Bruni and Porter (88).
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